Results 141 to 150 of about 2,032,731 (300)
Simvastatin mitigates placental hypoperfusion in OAPS by ameliorating abnormal uteromaternal hemodynamics and enhancing trophoblast invasion via optimized endothelial cell interactions under pathological shear stress, as evidenced by results from a placenta‐on‐a‐chip platform.
Hongli Liu +10 more
wiley +1 more source
Nitrous oxide and mood: metabolic mechanisms letter in response to Gill et al. [PDF]
Reynolds EH.
europepmc +1 more source
HUCMSC‐Apo‐mvs enhance peripheral nerve repair by modulating the inflammatory microenvironment (IME), primarily through coordinated actions on three functional cells. They recruit macrophages and promote their polarization from pro‐inflammatory M1 to anti‐inflammatory M2 phenotypes, increasing secretion of IL‐10 and VEGF.
Haolin Liu +21 more
wiley +1 more source
Merlin's disappearing act: NF2 loss conjures pancreatic cancer survival in the hostile tumor microenvironment. [PDF]
Ferreira S, Attardi LD.
europepmc +1 more source
This work presents ARC‐3D, a soft 3D model that recreates how brain support cells, called astrocytes, react to oxidative stress. The system visualizes rapid calcium changes and inflammatory signals, and shows how the drug KDS12025 can protect cells from damage. ARC‐3D offers a simple, reliable way to study early drivers of brain inflammation.
Ju‐Kang Kim +6 more
wiley +1 more source
The critical role of <i>hcpR</i> in regulating nitrosative stress defense in <i>Clostridioides difficile</i>. [PDF]
Kalra S, Ayinde TO, Olaitan AO.
europepmc +1 more source
Peptomer Linkers Enable Kinetic Control over Co‐Delivery of Multiple Chemotherapeutics
A key challenge in combinatorial chemotherapeutic drug delivery is independent control over release kinetics, especially with drugs of similar size and structure. Here, peptoid substitutions to proteolytically degradable peptides enabled the design of fast and slow‐releasing drug linkers.
Carolyn M. Watkins +3 more
wiley +1 more source
Mechanisms of lactylation modification in hepatocellular carcinoma treatment resistance. [PDF]
Zhu Y, Wang Z, Xi H, Lu W, Sun M, Lin X.
europepmc +1 more source
Metabolism and Inactivation of Progesterone
openaire +2 more sources

